{"schema_version":"secwatch.filing_event.v1","accession":"0001402479-23-000090","form_type":"8-K","ticker":null,"cik":"0001402479","company_name":"MedAvail Holdings, Inc.","filed_at":"2023-08-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.800490+00:00","generated_at":"2026-06-11T06:52:05.291912+00:00","sec_items":["5.05"],"event_type":"other","sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"confidence":"high","headline":"MedAvail Holdings amends Code of Conduct after retail pharmacy business sale","bullets":["Board approved amendments to Code of Conduct on August 17, 2023.","Changes primarily reflect sale of retail pharmacy services business.","Removed healthcare-specific references no longer applicable.","Added provisions on insider trading, antitrust, and international business laws.","Modified conflicts of interest disclosure requirements."],"urls":{"canonical":"https://secwatch.observer/filing/0001402479-23-000090","json":"https://secwatch.observer/filing/0001402479-23-000090.json","markdown":"https://secwatch.observer/filing/0001402479-23-000090.md","text":"https://secwatch.observer/filing/0001402479-23-000090.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1402479/000140247923000090/0001402479-23-000090-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1402479/000140247923000090/medavail-20230817.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T06:52:05.291912+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d7963e9da2fe4a70b08028229f00d8e5f2c27a12","claim":"MedAvail Holdings, Inc.: The Board of Directors approved amendments to the MedAvail Holdings, Inc. Code of Conduct and Ethics to reflect changes resulting from the sale of its retail pharmacy services business, remove healthcare-specific references, and add provisions on insider trading, antitrust, and international busines (effective 2023-08-17).","evidence_excerpt":"On August 17, 2023, the Board of Directors (the “ Board ”) of MedAvail Holdings, Inc., upon the recommendation of the Nominating and Corporate Governance Committee of the Board, approved amendments to the MedAvail Holdings, Inc. Code of Conduct and Ethics (the “ Code of Conduct ”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1402479/000140247923000090/0001402479-23-000090-index.htm","confidence":0.95,"family_label":"Governance Changes","details":[{"label":"Change","value":"code of ethics"},{"label":"Effective","value":"2023-08-17"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}